ES2094338T3 - Antagonistas de amino-acidos de excitacion. - Google Patents

Antagonistas de amino-acidos de excitacion.

Info

Publication number
ES2094338T3
ES2094338T3 ES92901599T ES92901599T ES2094338T3 ES 2094338 T3 ES2094338 T3 ES 2094338T3 ES 92901599 T ES92901599 T ES 92901599T ES 92901599 T ES92901599 T ES 92901599T ES 2094338 T3 ES2094338 T3 ES 2094338T3
Authority
ES
Spain
Prior art keywords
acid
amino
extation
antagonists
isomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92901599T
Other languages
English (en)
Spanish (es)
Inventor
Greg Scott Hamilton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Corp of North America
Original Assignee
Guilford Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharmaceuticals Inc filed Critical Guilford Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2094338T3 publication Critical patent/ES2094338T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/383—Cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES92901599T 1990-12-07 1991-12-04 Antagonistas de amino-acidos de excitacion. Expired - Lifetime ES2094338T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62416890A 1990-12-07 1990-12-07

Publications (1)

Publication Number Publication Date
ES2094338T3 true ES2094338T3 (es) 1997-01-16

Family

ID=24500939

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92901599T Expired - Lifetime ES2094338T3 (es) 1990-12-07 1991-12-04 Antagonistas de amino-acidos de excitacion.

Country Status (11)

Country Link
EP (1) EP0639197B1 (OSRAM)
JP (1) JP2721933B2 (OSRAM)
AT (1) ATE142220T1 (OSRAM)
CA (1) CA2097910A1 (OSRAM)
DE (1) DE69121920T2 (OSRAM)
DK (1) DK0639197T3 (OSRAM)
ES (1) ES2094338T3 (OSRAM)
GR (1) GR3021881T3 (OSRAM)
IE (1) IE75735B1 (OSRAM)
WO (1) WO1992010099A1 (OSRAM)
ZA (1) ZA919196B (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028213A (en) 1998-04-16 2000-02-22 Eastman Chemical Company Optically active cis-1,3-cyclohexanedicarboxylic acid monoesters with high enantiomeric purity and process for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761405A (en) 1987-03-04 1988-08-02 Nova Pharmaceutical Corporation Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency

Also Published As

Publication number Publication date
ZA919196B (en) 1992-09-30
EP0639197A1 (en) 1995-02-22
IE914256A1 (en) 1992-06-17
EP0639197B1 (en) 1996-09-04
DE69121920D1 (de) 1996-10-10
GR3021881T3 (en) 1997-03-31
JP2721933B2 (ja) 1998-03-04
WO1992010099A1 (en) 1992-06-25
JPH06505966A (ja) 1994-07-07
CA2097910A1 (en) 1992-06-08
ATE142220T1 (de) 1996-09-15
IE75735B1 (en) 1997-09-24
DK0639197T3 (OSRAM) 1997-02-24
EP0639197A4 (en) 1994-02-21
DE69121920T2 (de) 1997-04-03

Similar Documents

Publication Publication Date Title
DE69532162D1 (de) Cannabinoid-rezeptor-antagonisten
EA199700260A1 (ru) Готовая препаративная форма 2-метилтиенобензодиазепина для перорального введения и способ ее получения
MX19448A (es) Procedimiento para la prreparacion de compuestos antagonistas de los receptores de aminoacidos excitadores; compuestos obtenidos y composicion farmaceutica que los incluye.
FI933810A7 (fi) Virittyvien aminohappojen reseptoriantagonisteja
BG101110A (bg) Заместени пиримидинови съединения и тяхното използване
NO944578L (no) Eksitatoriske aminosyre reseptor antagonister
EP1017713A4 (en) CYCLIC AGONISTS AND ANTAGONISTS OF THE C5A RECEPTORS AND G-PROTEIN COUPLED RECEPTORS
PT894084E (pt) Derivados de acido cinamico e sua utilizacao como antagonistas de integrina
DE122006000012I1 (de) Lhrh antagonistische Peptide
DE69021618D1 (de) Antagonisten von exzitatorischen Aminosäuren.
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
DK0539503T3 (da) Excitatoriske aminosyreantagonister
BR9611509A (pt) Antagonistas de receptores de aminoácidos excitativos
IL94377A (en) Pyridine derivatives which antagonize the effects of excitatory amino acids upon the nmda receptor complex and pharmaceutical compositions comprising them
EA199800230A1 (ru) Тетрагидрохинолины в качестве антагонистов nmda (n-метил-d-аспарагиновой кислоты)
ES2180573T3 (es) Uso de derivados de indol como antagonistas de 5ht1.
FI924642A0 (fi) Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
FI940834A7 (fi) Eksitatoristen aminohapponeurotransmittereiden antagonisteina käyttöke lpoisia synteettisiä heteroaryylipolyamiineja
UA41300C2 (uk) Аналоги гормонів-антагоністів lhrh і спосіб їх отримання
DK0617616T3 (da) Potensering af NMDA-antagonister
AR004601A1 (es) Antagonistas de receptor de aminoacidos
MX9205216A (es) Derivados de amida substituida de antagonistas de piperizinilcan-forsulfonil oxitocina
DE69121920D1 (de) Antagonisten reizübertragender aminosäuren
IS4597A (is) Ný lyfjafræðileg notkun AII-viðtaka mótlyfja
DK0552712T3 (da) 8-(1-aminocycloalkyl)1,3-dialkylxanthinderivater som antagonister for adenosinreceptorer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 639197

Country of ref document: ES